CD24 gene exon 2 dimorphism does not affect disease susceptibility in Japanese sarcoidosis patients

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 27, Issue 1, 2010, Pages 64-69

  Tanizawa, K ^a   Handa, Tomohiro ^b   Nagai, S ^c   Ito, Y ^a   Watanabe, K ^a   Aihara, K ^a   Izumi, T ^c   Mishima, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c Clinical Research Center   (Japan)

Author keywords

CD24; Sarcoidosis; Single nucleotide polymorphisms

Indexed keywords

CD24 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPANESE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANTIGENS, CD24; ASIAN CONTINENTAL ANCESTRY GROUP; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOIDOSIS;

EID: 77957561571     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med 2008; 14: 434-9.
2. Rossman MD, Kreider ME, State of the Art. Lesson learned from ACCESS (A case controlled etiologic study of sarcoidosis). Proc Am Thorac Soc 2007; 4: 453-6.
3. Chambers CA, Krummel MF, Boitel B Hurwits A, Sullivan TJ et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 1996; 153: 27-46. (Pubitemid 27010762)
4. Handa T, Nagai S, Ito I, et al. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 190-6.
5. Handa T, Nagai S, Ito I, et al. Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 2005; 72: 243-8.
6. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-64.
7. Hubbe M, Altevogt P. Heat-stable antigen/CD24 on mouse T lymphocytes: evidence for a costimulatory function. Eur J Immunol 1994; 24: 731-7. (Pubitemid 24076642)
8. Liu Y, Jones B, Aruffo A, et al. Heat-stable antigen is a costimulatory molecule for CD4T cell growth. J Exp Med 1995; 175: 437-45
9. De Bruijn ML, Peterson PA, Jackson MR. Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. J Immunol 1996; 156: 2686-92.
10. Wu Y, Zhou Q, Zheng P, Liu Y. CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J Exp Med 1998; 187: 1151-6.
11. Zhou Q, Rammohan K, Lin S, et al. CD24 is a genetic modifier for risk and progression of multiple sclerosis. Proc Natl Acad Sci USA 2003; 100: 15041.
12. Sanchez E, Abelson AK, Sabio JM, et al. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2007; 56: 3080-6.
13. Rueda B, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA. Association of CD24 gene polymorphisms with susceptibility to biopsyproven giant cell arteritis. J Rheumatol 2008; 35: 850-4. (Pubitemid 351747127)
14. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
15. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981; 27: 1922-5.
16. Dupont WD, Plummer WD. Power and Sample Size Calculations for Studies Involving Linear Regression, Controlled Clinical Trials 1998; 19: 589-601. (Pubitemid 29057724)
17. Sharma OP. Sarcoidosis and other autoimmune disorders. Curr Opin pilm Med 2002; 8: 452-6.
18. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE. Encephalitogenic T cells in the B10. PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989; 124: 132-43.
19. Zissel G, Prasse A, Müller-Quernheim J. Sarcoidosis - immunopathogenetic concepts. Semin Respir Crit Care Med 2007; 28: 3-14.
20. Larsen CE, Alper CA. The genetics of HLA-associated disease. Curr Opin Immunol 2004; 16: 660-7.
21. Traherne JA, BArcellos LF, Sawcer SJ, et al. Association of the truncationg splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet 2006; 15: 155-61.
22. Wang L, Lin S, Rammohan KW, et al. A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet 2007; 3: e49.
23. Westney GE, Judson MA. Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 2006; 27: 453-62.